Your browser is no longer supported. Please, upgrade your browser.
Settings
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E13.56 EPS (ttm)2.96 Insider Own0.20% Shs Outstand2.50B Perf Week3.21%
Market Cap99.21B Forward P/E13.10 EPS next Y3.06 Insider Trans0.00% Shs Float2.49B Perf Month4.72%
Income7.45B PEG3.01 EPS next Q0.59 Inst Own12.60% Short Float0.82% Perf Quarter12.97%
Sales45.96B P/S2.16 EPS this Y23.20% Inst Trans6.70% Short Ratio4.34 Perf Half Y6.10%
Book/sh8.44 P/B4.76 EPS next Y12.89% ROA6.50% Target Price47.27 Perf Year-0.15%
Cash/sh2.76 P/C14.53 EPS next 5Y4.50% ROE36.70% 52W Range33.26 - 42.40 Perf YTD9.10%
Dividend2.12 P/FCF26.97 EPS past 5Y-7.90% ROI17.30% 52W High-4.95% Beta0.69
Dividend %5.28% Quick Ratio0.60 Sales past 5Y7.30% Gross Margin67.60% 52W Low21.17% ATR0.43
Employees94066 Current Ratio0.90 Sales Q/Q-18.40% Oper. Margin23.00% RSI (14)71.32 Volatility0.88% 0.89%
OptionableYes Debt/Eq1.76 EPS Q/Q-31.80% Profit Margin16.20% Rel Volume0.67 Prev Close40.15
ShortableYes LT Debt/Eq1.55 EarningsApr 28 BMO Payout53.50% Avg Volume4.71M Price40.30
Recom2.00 SMA203.27% SMA505.96% SMA2008.35% Volume1,299,681 Change0.37%
Mar-23-21Downgrade SVB Leerink Outperform → Mkt Perform
Feb-04-21Downgrade Deutsche Bank Hold → Sell
Jan-20-21Downgrade Credit Suisse Neutral → Underperform
Jan-15-21Initiated Deutsche Bank Hold
Nov-02-20Upgrade Liberum Hold → Buy
Sep-29-20Initiated Berenberg Buy
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Jun-14-21 08:42AM  
07:53AM  
07:24AM  
07:18AM  
07:00AM  
06:46AM  
Jun-13-21 08:00PM  
Jun-11-21 01:57PM  
Jun-10-21 05:52AM  
Jun-09-21 02:50PM  
03:43AM  
Jun-08-21 02:03PM  
11:45AM  
Jun-07-21 01:45PM  
Jun-04-21 02:50PM  
02:34PM  
02:12PM  
Jun-03-21 01:36PM  
05:52AM  
Jun-02-21 05:18PM  
02:15PM  
01:44AM  
Jun-01-21 02:57PM  
02:09PM  
10:27AM  
07:45AM  
May-31-21 05:14PM  
May-30-21 09:19AM  
May-29-21 07:11AM  
May-28-21 02:18PM  
01:43PM  
10:44AM  
08:48AM  
May-27-21 04:13PM  
02:10PM  
01:16PM  
10:40AM  
10:12AM  
08:39AM  
08:32AM  
08:10AM  
08:07AM  
07:44AM  
07:20AM  
06:29AM  
05:59AM  
04:48AM  
May-26-21 06:57PM  
05:55PM  
02:05PM  
12:21PM  
May-25-21 04:50PM  
02:44PM  
May-24-21 02:28PM  
01:51PM  
12:27PM  
06:49AM  
May-23-21 08:17AM  
May-21-21 06:21PM  
01:43PM  
11:56AM  
09:51AM  
08:21AM  
May-20-21 01:58PM  
06:08AM  
May-19-21 01:49PM  
06:44AM  
May-18-21 01:11PM  
10:45AM  
09:24AM  
09:00AM  
08:51AM  
08:41AM  
08:30AM  
04:28AM  
12:35AM  
May-17-21 10:59AM  
08:25AM  
07:07AM  
04:36AM  
01:51AM  
01:30AM  
May-16-21 08:00PM  
08:00PM  
May-14-21 04:55PM  
03:29PM  
01:40PM  
May-13-21 05:21PM  
02:27PM  
02:16PM  
09:20AM  
May-12-21 04:19PM  
02:14PM  
10:15AM  
May-11-21 02:09PM  
12:22PM  
May-10-21 01:53PM  
May-09-21 02:06PM  
May-08-21 10:44AM  
08:00AM  
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerMay 20Sale12.2532,005,260392,064,4350May 24 05:04 PM
GLAXOSMITHKLINE PLCDirectorJul 21Buy18.00361,1116,499,9982,248,304Jul 22 04:18 PM